BPC 157 Banned: Key Facts on the Latest FDA Decision Cagrilintide US FDA to convene expert panel to review wider access to some peptides Reuters BPC 157 Peptide Therapy in Coralville Relive Health BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with